Efficacy of Nitrous Oxide in OCD: Pilot Study

• Status: Recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Collaborator: Brain & Behavior Research Foundation
• Treatments: Nitrous Oxide

Criteria

Inclusion Criteria:

• Age 18-65

• Primary diagnosis of OCD

• Sufficient severity of OCD symptoms

• Ability to tolerate a treatment-free period

• Capacity to provide informed consent

Exclusion Criteria:

• Psychiatric or medical conditions that make participation unsafe

• Pregnant or nursing females

• Concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)